Use of compound acid (+) 1,4 - dihydro - 7 - (3S, 4S) - 3 - metu00f3xi - 4 - (methylamino) - 1 - pirrolid inil - 4 - oxo - 1 - (2 - (2-amino-4-thiazolyl) - 1,8 - naftiridina - 3 - carboxu00eclico enantiomericamente pure, and compound acid (+) 1,4 - dihydro - 7 - (3S, 4S) - 3 - metu00f3xi - 4 - (methylamino) - 1 - pirrolidi nil - 4 - oxo - 1 - (2 - (2-amino-4-thiazolyl) - 1,8 - naftiridina - 3 - carbo Xu00eclico enantiomericamente pure

摘要

Use of compound acid (+) 1,4 - dihydro - 7 - [(3S, 4S) - 3 - metu00f3xi - 4 - (methylamino) - 1 - pirrolid inil] - 4 - oxo - 1 - (2 - (2-amino-4-thiazolyl) - 1,8 - naftiridina - 3 - carboxilico enantiomericamente pure, and compound acid (+) 1,4 - dihydro - 7 - (3S, 4S) - 3 - methoxy - 4 - (methylamino) - 1 - pirrolidinil] - 4 - oxo - 1 - (2 - (2-amino-4-thiazolyl) - 1,8 - naftiridina carbox - 3 - u00eclico enantiomericamente pure "methods of treatment, prevention or control of cancer,Including some leukemias, are described. The methods comprise the administration of acid (+) 1, 4 - dihydro - 7 - (3S, 4 (s) - 3 - metu00f3xi - 4 - (methylamino) - 1 - pirrolidinil] - 4 - oxo - 1 - (2 - (2-amino-4-thiazolyl) - 1,8 - naftiridina - 3 - carboxylic enantiomericamente pure. Methods are also provided with detection using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy.Pharmaceutical compositions and single unit dosage forms suitable for use in such methods are also described.